Skip to main content

CORRECTION article

Front. Immunol., 23 August 2024
Sec. Molecular Innate Immunity

Corrigendum: Genetic investigation of Nordic patients with complement-mediated kidney diseases

Viktor RydbergViktor RydbergSigridur Sunna AradottirSigridur Sunna AradottirAnn-Charlotte KristofferssonAnn-Charlotte KristofferssonNaila SvitachevaNaila SvitachevaDiana Karpman*Diana Karpman*
  • Department of Pediatrics, Clinical Sciences Lund, Lund University, Lund, Sweden

A Corrigendum on
Genetic investigation of Nordic patients with complement-mediated kidney diseases

By Rydberg V, Aradottir SS, Kristoffersson A-C, Svitacheva N and Karpman D (2023). Front. Immunol. 14:1254759. doi: 10.3389/fimmu.2023.1254759

In the published article, there was an error in Table 3 as published. Under the heading C3, rowc.4030-4C>G was under the ACMG classification stated as “P” when it should be “LB”. Under the heading CFHR2, row R141S, “c.423G>A” should have been written as “c.423G>T”. And finally, under the heading CLU, row K444Q, “c.1339A>C” should be corrected to “c.1330A>C”. The corrected Table 3 and its caption appear below.

Table 3
www.frontiersin.org

Table 3. Variants in C3G patients included in this study.

In the published article, there was an error in Supplementary Table 1. The C3 level of patient 314 was given as “normal” when it should have been written as “low”. The corrected Supplementary Material File has now been published.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: complement, atypical hemolytic uremic syndrome, C3 glomerulopathy, membranoproliferative glomerulonephritis, genes

Citation: Rydberg V, Aradottir SS, Kristoffersson A-C, Svitacheva N and Karpman D (2024) Corrigendum: Genetic investigation of Nordic patients with complement-mediated kidney diseases. Front. Immunol. 15:1476204. doi: 10.3389/fimmu.2024.1476204

Received: 05 August 2024; Accepted: 08 August 2024;
Published: 23 August 2024.

Edited and Reviewed by:

Francesca Granucci, University of Milano-Bicocca, Italy

Copyright © 2024 Rydberg, Aradottir, Kristoffersson, Svitacheva and Karpman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Diana Karpman, diana.karpman@med.lu.se

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.